Pricing Log in Create free account
Friday 6 November 2026 Export TECH’s income statement to Excel — free account

Bio-Techne Corp

TECH Healthcare Biotechnology

Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025.

Revenue
+1.33%
EPS
+418.2%
Free cash flow
−6.83%
Total debt
−42.2%

Quarter to June 2026, against a year earlier

72.79 0.13 +0.18%
Market cap
$11.4B
P/E
62.2×
Fwd P/E
54.2×
Dividend yield
0.44%
F-score
9/9
Altman Z
15.50
Beneish M
−2.52
Dividend safety
78/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Bio-Techne Corp 8-K filed Nov 4, 2026

Period ended Nov 3, 2026 · Filed · accepted 8:30 PM ET · Document on sec.gov · Filing index

8.01 Other events; 9.01 Financial statements and exhibits

What it says

On November 3, 2026, Bio-Techne announced a dividend of $0.08 per share for the quarter ended September 30, 2026. It is payable November 23, 2026, to common shareholders of record at the close of business on November 13, 2026, provided the previously announced transaction with Merck KGaA, Darmstadt, Germany has not closed by that time. The board will consider future cash dividends quarterly, as applicable.